# Genworth Financial, Inc. (GNW)

> Source: Nexqual · https://nexqual.com/GNW · data as of 2026-10-29 20:00 UTC · cite as "Nexqual, Genworth Financial, Inc. (GNW), nexqual.com/GNW" · informational, not investment advice.

**Price:** USD 9.03 (+1.69% on the day) · last close of Oct 29, 2026; US market closed, not a live price. Prev close 8.88 · day 8.94–9.07 · 52w 7.84–10.69 · market cap $3.41B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $7.40B, net income $212M (2.9% margin) (SEC filings).
- Valuation: P/E 16.1x (avg 22.9x at the last 3 fiscal year-ends), net cash $486M.
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 10.5 (range 10.5–10.5).
- Total return with dividends: 1Y +5.5% vs S&P 500 +14.8%; 5Y +119.7% vs S&P 500 +79.1%.
- Next earnings: 2026-11-04, EPS estimate USD 0.27, revenue estimate $0K. All companies reporting that day: https://nexqual.com/earnings/2026-11-04
- Dividend: GNW paid no cash dividend in the last five years.
- Short interest: 3.42% of float (as of 2026-10-15), 1.9 days to cover.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $7.82B | $7.50B | $7.49B | $7.29B | $7.30B | $7.40B |
| Operating income | $474M | $818M | $41.0M | — | — | — |
| Net income | $850M | $916M | $76.0M | $299M | $223M | $212M |
| EPS (diluted) | $1.65 | $1.79 | $0.16 | $0.68 | $0.54 | — |
| Operating margin | 6.1% | 10.9% | 0.5% | — | — | — |
| Net margin | 10.9% | 12.2% | 1.0% | 4.1% | 3.1% | 2.9% |
| Revenue growth | -5.6% | -4.2% | -0.1% | -2.6% | +0.1% | — |
| Cash + short-term investments | $1.57B | $1.80B | $2.21B | $2.05B | $2.04B | — |
| Total debt | $1.90B | $1.61B | $1.58B | $1.52B | $1.51B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 16.1x · P/S 0.5x · EV/Sales 0.4x · P/B 0.4x · Earnings yield 6.21% · Buyback yield (TTM) 8.79% · Net cash $486M · EV $2.93B
P/E at fiscal year-ends: Dec 2025 16.8x, Dec 2024 10.3x, Dec 2023 41.7x.

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 10.5 (low 10.5, high 10.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-09 | Keefe, Bruyette & Woods | Downgrade | Outperform → Market Perform | $11.5 → $10.5 |
| 2026-09-16 | Keefe, Bruyette & Woods | Target lowered | Outperform | $12 → $11.5 |
| 2026-07-13 | Keefe, Bruyette & Woods | Target raised | Outperform | $11 → $12 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-30) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +5.5% | +119.7% |
| S&P 500 (SPY) | +14.8% | +79.1% |
| Per year | +5.5% | +17.0% |
| Volatility (annualized) | 23.0% | 32.1% |
| Max drawdown | -16.8% (Sep 2026→Oct 2026) | -24.1% (Feb 2023→Mar 2023) |

## Dividends
GNW paid no cash dividend in the last five years.

## Short interest
8,562,503 shares sold short, 3.42% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 9,721,886 shares (-11.9%). Days to cover: 1.9 (short shares ÷ average daily volume).

## Peers (Insurance - Life)
FG (F&G Annuities & Life, Inc.) USD 21.05 +2.18% · BHF (Brighthouse Financial, Inc.) USD 42.98 -1.89% · CNO (CNO Financial Group, Inc.) USD 55.17 +1.45% · LNC (Lincoln National Corporation) USD 41.37 +1.75% · PRI (Primerica, Inc.) USD 283.55 +1.61% · JXN (Jackson Financial Inc.) USD 135.97 +1.09%

## More
Full page: https://nexqual.com/GNW · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)


Other companies that name GNW in their own reports (relationship from GNW's side):

| Relationship | Company | Their filing | Sentence |
|---|---|---|---|
| partner | Enact Holdings, Inc. (ACT) | 10-K 2026-02-27 | "We also have entered into a registration rights agreement with Genworth, which will give Genworth a right, subject to certain conditions, to require us to register the sale of our common stock benefic…" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.27 | $0.07 | +285.7% | $0 | 1 |
| Next quarter (ends 2026-12-31) | $0.26 | $0.07 | +271.4% | $0 | 1 |
| Current fiscal year (ends 2026-12-31) | $1.10 | $0.41 | +168.3% | $0 | 1 |
| Next fiscal year (ends 2027-12-31) | $1.10 | $0.36 | +205.6% | $0 | 1 |

## Earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.29 | $0.27 | Beat +7.4% | — |
| — | Quarter ended Mar 31, 2026 | $0.28 | $0.20 | Beat +40.0% | — |
| — | Quarter ended Sep 30, 2025 | $0.04 | $0.05 | Miss −20.0% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).